Prevalence of Depression in Women with Polycystic Ovary Syndrome (PCOS)
Parole chiave:
Poly cystic ovary syndrome, Depression, Hirsutism, Androgenic alopecia.Abstract
Poly cystic ovary syndrome (PCOS) is a frequent endocrine abnormality affecting 5–10% women of reproductive age worldwide. PCOS is a heterogeneous condition representing diverse clinical, reproductive, metabolic and psychological implications like hirsutism, infertility, androgenic alopecia, insulin resistance, diabetes mellitus type 2, and cardiovascular diseases. There is enormous data regarding PCOS association with clinical manifestations’ and metabolic diseases but little is known about the risk of association of psychological disorders like depression and anxiety with PCOS. The aim of the present study was to estimate prevalence of depression in women with PCOS compared with controls. This cross sectional study was performed on 22 PCOS patients and 302 control women. The main outcome measures include Beck Depression Inventory and General Health Questionnaire -12. The prevalence of depression in PCOS women was found to be 90% according to Beck Depression Inventory and 59% were considered as cases suspicious for mental disorder. It was found that PCOS women were having extremely high prevalence of depression so the psychological treatment must be included in order to improve the mental status of patients. PCOS considerably increases the chance of a women developing depression. Although depression can result in destructive emotional and psychological disturbances, a healthy lifestyle, sufficient exercise, nutritious diet and prescribed medications can help in reduction of PCOS depression symptoms.Keywords: Polycystic ovary syndrome, depression, Hirsutism, Androgenic alopecia
Pubblicato
Fascicolo
Sezione
Licenza
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
· I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
· I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
· I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
· I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
_______________
We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |
